https://prabadinews.com/
  • October 8, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

Lonapegsomatropin-Tcgd Receives FDA Approval for Growth Hormone Deficiency

Lonapegsomatropin-Tcgd Receives FDA Approval for Growth Hormone Deficiency

FDA approves lonapegsomatropin for once-weekly treatment of growth hormone deficiency, offering a promising alternative for improved patient adherence and outcomes.

administrator

Related Articles